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Abstract 
Human gingival fibroblasts (HGFs) cell sheets have a potential use for in vivo wound healing due to the 
ability of HGFs to adopt a contractile phenotype which is typically expressed during extracellular matrix 
tissue remodeling. For this purpose, we developed a chemically detachable platform based on 
poly(allylamine hydrochloride)/poly(styrene sulfonate) multilayer film built on a sacrificial precursor 
film which served as a substrate for HGF cell layer formation. The sacrificial precursor film, based on 
disulfide-containing polycation and polyanion, is degradable under mild conditions compatible for cell 
sheet detachment. Cellular viability and cell phenotype analysis of HGF show that the designed 
platform promotes cell phenotype switch into contractile phenotype, maintained after cell sheet lift-off. 
This contractile phenotype is acquired by fibroblasts during in vivo wound healing and tissue 
remodeling. HGFs cell sheet fragments, obtained by this detachment process, could be cultured later on 
showing a good retention of the typical spindle-shape of differentiated cells after 10 days of culture. 
HGFs cell sheets have great potential applications as autologous substrates for tissue repair and cellular 
synthetic platforms for research on connective tissue diseases or evaluation of novel therapeutic agents. 
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A chemically detachable platform was 
developed based on PSS/PAH multilayer films 
built on a sacrificial precursor film, degradable 
under mild conditions through reduction of 
disulfide-containing polyelectrolytes. Growth 
of human fibroblasts on this platform 
promotes cell phenotype switch into 
contractile phenotype necessary for wound 
healing, which is maintained after cell sheet 
lift-off. The obtained cell sheets could be used 
as autologous explant. 
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Introduction 
Aimed at the maintenance and the recovery of native functions, cell sheet engineering is emerging as a 
promising approach to construct in vitro tissues or organs for transplantation into damaged host tissues.1, 
2 Different strategies of cell sheet detachment were successfully developed such as the use of thermo-
responsive polymers, 3-5 bioresorbable layers,6, 7 enzymatic digestion of the substrate,8 magnetic force 
based9 or electrochemical based detachment.10-12 However, versatile and mild methods for cell sheets 
development remain a challenge due to persisting drawbacks such as irrelevant control over gene 
expression induced by the detachment process.13 Enzymatic treatment may induce damage to cell 
membranes by hydrolyzing various membrane-associated proteins, resulting in impairment of cell 
functions. Strategies based on biodegradable polymers (such as polyglycolic acid, poly-L-lactic acid, 
polycaprolactone) provide promising results in vitro, but in vivo data revealed severe limitations, 
together with too fast degradation rates and promotion of acute inflammatory responses.14-16 
Polyelectrolyte multilayer (PEMs) films, obtained by the alternate deposition of polycations and 
polyanions, emerged as a simple approach to modify surfaces in a controlled way.17, 18 Poly(allylamine 
hydrochloride) and poly(styrene sulfonate) (PAH/PSS) films constitute a good substrate for 
differentiated cell culture and then tissue engineering.19-25 Those films even accelerate the 
differentiation of circulating vascular progenitor cells, harvested from peripheral blood into mature and 
functional SMCs or ECs.26, 27 However, tissues formed from cells cultured on PSS/PAH films are 
difficult to harvest while preserving cell-cell junction and their deposited extracellular matrix (ECM) 
compounds. Liao et al. used thermoreponsive PEMs for an efficient removal of human mesenchymal 
stem cells28. Depending on the substrate on which PEM films were deposited, free standing films were 
lifted off using extreme acidic conditions for silica or silicon substrates, acetone for cellulose 
substrates,29 tetrahydrofuran or basic conditions for polystyrene substrates.30 Organic solvent and 
extreme pH are however incompatible with cell viability and cannot be used to detach cellular sheets 
grown on PEM platforms. Buck et al. reported the detachment of free standing thin films based on 
azalactone-containing polymer multilayers by immersion in mildly acidic aqueous environment.31 
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In this study, we describe a novel biocompatible and easily applicable chemical method for harvesting 
cell tissues in vitro. PSS/PAH multilayer films, that served as a substrate for the formation of cell layers, 
were built on a sacrificial precursor film. This sacrificial film, based on disulfide-containing polycation 
and polyanion, was degraded by a reducing agent under mild conditions, compatible with cell viability 
and phenotype stability. Cleavable disulfide bond under reductive conditions is widely accepted and has 
been applied to produce porous multilayer films,32 and in drug33-35 or gene delivery.36, 37 Human gingival 
fibroblasts (HGFs) were used to produce cell sheets because they are an easy source of autologous 
primary cells with little donor-site morbidity. They are the main population in oral mucosa of non-
myocyte cells dedicated to establishment and maintenance of ECM and are useful graft materials for the 
regeneration of alveolar bone and periodontal ligaments.38 HGFs sheets have thus a potential use for in 
vivo wound healing due to HGFs ability to adopt a contractile phenotype during tissue remodeling. 
 
Results and discussion 
Characterization of Human Gingival Fibroblasts cell sheets cultured on PAH/PSS films. We first 
investigated the HGFs behavior on PAH/PSS multilayers compared to a glass substrate. Although the 
morphological observations of HGFs performed after 7 days of culture did not show any difference 
between (PAH/PSS)10-PAH films and glass substrate, the mitochondrial activity assessed by Alamar 
BlueTM reagent showed a higher activity for cells cultivated on (PAH/PSS)10-PAH films (Figure S-1 in 
Supporting Information, SI). Cytoskeleton staining showed that HGFs cells are well spread and 
organized. Indeed, F-actin staining shows the presence of polymerized actin fibers lying parallel one to 
each other on both glass and PEMs substrate (Figure 1). The density of F-actin fibers seems higher on 
PAH/PSS films ended by PAH. All these results demonstrate a better proliferation of HGFs on 
PAH/PSS films compared to glass substrate. 
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Figure 1: Cytoskeleton visualization of HGFs by F-actin filament stained with phalloidin® (red 
labelling) observed by confocal microscopy, after 14 days of culture on a (a) glass substrate and (b) 
(PAH/PSS)10-PAH film. 
 
In vivo during wound healing and tissue remodeling, the fibroblasts acquire a contractile phenotype39 by 
increasing the expression of contractile proteins such as alpha smooth muscle actin (α-SMA). Recently, 
Berthelemy et al showed the high expression of this protein for progenitor cells cultivated on PAH/PSS 
films.27 The expression of contractile proteins of HGFs, seeded on glass and PSS/PAH films, has been 
checked at both gene and protein level. The α-SMA gene, expressed by cells, was investigated by 
quantitative Real-time Polymerase Chain Reaction (qRT-PCR). These experiments included three 
housekeeping gene controls as internal references hypoxanthine phosphoribosyl transferase1 (HPRT1), 
beta-2 microglobulin (B2M) and glyceraldehyde phosphate dehydrogenase (GAPDH). HPRT1, related 
to nucleotide metabolism, is generally recognized to be independent on phenotype. B2M and GAPDH 
were selected for the stability of their expression during wound healing.40 Triplicate samples of cells, 
grown on glass and (PAH/PSS)10-PAH films, were analyzed after 5, 15 and 30 days of culture. Figure 2 
shows, three to four times higher levels of α-SMA mRNA for cells cultivated on PEMs in comparison to 
glass. PSS/PAH films dramatically promote the expression of α-SMA gene related to the contractile 
protein. 
a b 
20 µm 20 µm 
 7 
-SMA
Time (days)
5 15 30
R
N
A
 (
n
g
)
0
100
200
300
400
500
Glass 
(PAH/PSS)
10
-PAH 
 
Figure 2: α-SMA mRNA quantification of HGFs cultivated on glass substrate and (PAH/PSS)10-PAH 
films during 5, 15 and 30 days. 
 
Figure 3: Detection of α-SMA marker (green labeling) by immunochemistry and nuclei blue 
counterstaining of HGFs cultured (a) on glass substrate and (b) (PAH/PSS)10-PAH after 1, 5 and 15 
days. The scale bars represent 100 µm. 
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The expression of α-SMA contractile protein was checked by immunocytochemistry staining. Almost 
all HGFs cultivated on PAH/PSS films were positive to α-SMA marker after 15 days (Figure 3). 
Statistical analysis showed significant differences (P < 0.001 by Mann-Whitney test) in the number of 
HGFs acquiring contractile phenotype on PAH/PSS films compared to glass substrate from the fifth day 
of culture (Figure S-2 in SI). After 15 days, the number of HGFs with contractile phenotype are 
increased by about 36% when cultured on PAH/PSS films compared to glass substrate (control: 201 ± 
25 per mm2; (PAH/PSS)10-PAH film: 273 ± 33 per mm
2). The contractile phenotype of HGFs is more 
pronounced when seeded on PAH/PSS films compared to glass substrate. In addition to the expression 
of the contractile markers, tissue healing needs to have an appropriate ECM deposition.39 Then, the 
secretory activities of HGFs cultivated on PAH/PSS films were investigated by immunocytochemistry. 
At the beginning of wound healing, collagen I (COL1) is the main component of the extracellular matrix 
produced by fibroblasts. At the wound level, tissue homeostasis is controlled by proteolytic enzymes 
such as matrix metalloproteinase-2 (MMP-2). HGFs cultivated on PAH/PSS express both pro-COL1 
and pro-MMP-2 proteins (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Detection of (a) pro-COL1 (green labelling) and (b) pro-MMP2 (green labelling) by 
immunochemistry and blue counterstaining of HGFs nuclei after 15 days culture on (PAH/PSS)10-PAH 
film. 
 
These results confirm an advantage for PAH/PSS films in terms of fibroblast functionality (contractility 
and homeostasis properties). These properties are essential for connective tissue remodeling during 
normal wound healing.41 Production of cell sheets expressing an accurate phenotype would be of 
interest as substrate for tissue repair. 
20 µm 20 µm 
a b 
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Buildup and degradation of disulfide containing polyelectrolyte films. PAH/PSS films ended by 
PAH have been shown to be appropriated films for HGFs cells culture and even suitable platforms for 
cells sheet engineering. In order to detach the HGFs cell layer obtained on PAH/PSS films, we 
synthesized by polymerization cleavable polyanion (poly(vinyl benzoic acid, PVBACOO-) and 
polycation (polycationic derived of poly(vinyl benzoic acid), PVBANH3
+) (Figure 5). Both polymer 
backbones include disulfide bonds that can be reduced by tris(2-carboxyethyl)phosphine (TCEP). They 
are thus cleavable into small molecular fragments. Those polyelectrolytes, soluble in water, were used 
to build a sacrificial film on which a capping PAH/PSS film was deposited in order to detach it later on 
by contact with TCEP. 
 
 
 
 
 
 
 
Figure 5: Chemical formulas of cleavable polyelectrolytes PVBACOO- and PVBANH3
+ 
 
 
 
 
 
 
 
 
Figure 6: Thickness evolution of (a) PEI-(PVBACOO-/PVBANH3
+)7 and (b) PEI-(PVBACOO
-
/PVBANH3
+)12-(PSS/PAH)9 multilayer films, determined by QCM, as a function of the last layer 
deposited, followed by four injections of 5 mM TCEP solution. A represents the polyanion PVBACOO- 
and B represents the polycation PVBANH3
+. 
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PVBACOO-/PVBANH3
+ multilayer films, built in physiological conditions (150 mM NaCl, pH 7.4), 
grows linearly with the number of deposited layers (Figure 6a). After contact with 3 mL of TCEP 
solution at 5 mM by three successive injections, the film is dissolved at 96% in thickness. In the case of 
PEI-(PVBACOO-/PVBANH3
+)12-(PSS/PAH)9 films, the contact with TCEP leads to the degradation of 
60% in film thickness (Figure 6b). Atomic force microscopy (AFM) was used to monitor the 
topography and the thickness of PVBACOO-/PVBANH3
+ films with and without the capping PAH/PSS 
film. As shown in Figure 7a, the PEI-(PVBACOO-/PVBANH3
+)10 film is homogeneous and shows a 
roughness of 8 nm (Figure S-3a in SI). After 30 minutes of contact with TCEP, the film remained 
homogenous (Figure S-3b) with a roughness of 3 nm but its dry thickness decreased from 32 to 5 nm 
(Figure 7b). Chen et al. 32 showed the formation of pores on multilayered thin films containing a blend 
of reducible polycations, based on cleavable disulfide bonds. In this work, a non-reducible polyanion 
was employed. No pore formation was observed in our system which is composed of both reducible 
polycations and polyanions. TCEP treatment leads to almost complete film dissolution. When a capped 
PAH/PSS film is built on top of PVBACOO-/PVBANH3
+, an homogeneous film is obtained with a 
higher roughness, about 14 nm compared to the 3 nm of the non-capped film (Figure S-3c in SI). TCEP 
treatment of the PEI-(PVBACOO-/PVBANH3
+)10-(PSS/PAH)10 film induced an homogeneous decrease 
of the dry thickness from 58 à 30 nm with almost no change in roughness (Figure 7c and 7d, Figure S-
3d in SI). Finally, the (PVBANH3
+/PVBACOO-)10-(PAH/PSS-Rhodamine)10-PAH architecture was 
built and incubated during 10 min in 5 mM TCEP solution. Fluorescent microscopy images confirmed 
the delamination of the PEM and the presence of PSS-Rhodamine on the released membrane after 
TCEP treatment (Figure S-4 in SI). 
 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Typical AFM 3D images, obtained in contact mode in dry state, of PEI-(PVBACOO-
/PVBANH3
+)10 film (a) before and (b) after TCEP treatment (5 mM, 30 min) and of PEI-(PVBACOO
-
/PVBANH3
+)10-(PSS/PAH)10 film (c) before and (d) after TCEP treatment (5 mM, 30 min). The films 
were scratched before observation. 
 
a b 
c d 
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Detachment of cell sheet and cell phenotype characterization. HGFs viability remains similar for 
PSS/PAH films built either directly on the glass substrate or on a PVBANH3
+/PVBACOO- sacrificial 
platform (Figure S-1 in SI). To test the cytotoxicity of the reductive agent, HGFs previously cultured on 
glass substrate during 7 days were incubated with a 5 mM TCEP solution (Figure S-5 in SI). TCEP 
solution does not show any cytotoxicity to HGFs up to 30 minutes of contact.  
 
 
Figure 8. Images obtained by optical (a) microscopy and (b) macroscopy of a HGFs cell sheet, cultured 
for 30 days on a (PVBANH3
+/PVBACOO-)10-(PAH/PSS)10-PAH film, recovered from mild chemical 
treatment during 30 min: the areas represent respectively (I) the glass substrate, (II) and (II’) free 
standing HGFs cell sheet and (III) HGFs cell layer. 
 
After 30 days of culture on (PVBANH3
+/PVBACOO-)10-(PAH/PSS)10-PAH, HGFs cell layers were 
incubated with 5 mM TCEP for less than 30 min. At the beginning of the process, the detached part of 
the HGFs cell sheets (II) remained connected to the cell layer (III) that still adhered to the surface 
(Figure 8a). Figure 8b shows a macroscopic image of the obtained free standing cell sheet (II’) after 
total detachment. HGFs sheets were then characterized by immunochemical detection of COL1 and α-
SMA. Immunostaining revealed the preservation of secreted pro-COL1 and α-SMA expression 
suggesting that TCEP treatment had no effect on HGF tissue integrity (Figure 9). 
III 
II 
I 
100 µm 1 mm 
a b 
II’ 
II 
I 
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Figure 9: Detection of pro-COL1 (red labeling) and α-SMA (green labeling) markers by 
immunochemistry and blue counterstaining of HGFs nuclei after 30 days culture on a 
(PVBANH3+/PVBACOO-)10-(PAH/PSS)10-PAH film after detachment (a, b and d) and (c) before 
detachment of the cell sheet. 
 
A (PVBANH3
+/PVBACOO-)10-(PAH/PSS-Rhodamine)10-PAH film was also used as a substrate for 
HGFs culture for 30 days and underwent the TCEP treatment. Figure S-6 in SI shows the presence of 
PSS-Rhodamine in the detached cell sheet showing the integrity of PAH/PSS film. PAH/PSS films 
constitute a good substrate for differentiated cell culture19-25 but also for the differentiation of stem cells 
into mature and functional SMCs or ECs.26, 27 Recently, Guillaume-Gentil et al.42 report the use of 
PAH/PSS thin films as substrate for the growth and subsequent release under electrochemical control of 
mesenchymal stem cell sheets that keep their mesodermal plasticity. These studies and our results show 
a good biocompatibility of PSS/PAH films. 
Cell migration is an important characteristic for tissue healing. According to the explants technique, we 
have seeded fragments of detached cell sheet on a new glass substrate. After 30 days of HGFs culture 
(Figure 10a) and detachment, fragments of the detached cell sheet were put in culture to check the 
a 
100 µm 
b 
100 µm 
c 
20 µm 
d 
20 µm 
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compatibility of the detachment procedure (Figure 10b). As soon as three days of culture, cells migrated 
from the cell sheet fragment (I) to the glass substrate. After 10 days of culture, outgrowth of cells from 
the cell sheet fragments was observed with retention of the typical spindle-shape of differentiated cells 
(Figure 10c and 10d). These results demonstrate that the detached cells kept their migration property. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 10: Phase contrast microscopy images of HGFs cell sheet after 15 days of culture on a 
(PVBANH3
+/PVBACOO-)10-(PAH/PSS)10-PAH film (a) before detachment, (b) detached and 
transferred on a new substrate, (c) after 3 days of culture and (d) after 10 days of culture. (I) represents 
the initially detached cell sheet. 
 
A major advantage of this chemically detachable platform, based on PEMs, concerns the ability to be 
equipped by an additional multiple functionalization with growth factors that could be necessary to 
engineer specific demanding cell phenotypes. Moreover, the use of a chemically degradable platform 
does not need dedicated apparatus as electrochemical or magnetic force apparatus. 
 
Conclusion 
c 
100 µm 
a 
100 µm 
I 
b 
100 µm 
d 
100 µm 
I 
I 
I 
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In this work, we describe a platform to produce detachable human autologous cell sheets. The obtained 
results demonstrate the ability of the platform not only to drive HGFs adhesion and proliferation but 
also to change their morphology to spread and express activation-dependent phenotypes. Specifically, 
(PVBANH3
+/PVBACOO-)10-(PAH/PSS)10-PAH platform promotes HGFs conversion to the contractile 
phenotype, which is maintained after cell sheet lift-off. In this respect, the method could provide 
fibroblast-seeded substrates having the potential to reorganize ECM and thereby to confer adaptation to 
tissue injury. As such, the construct described here could be envisioned as substrate for tissue repair. It 
could also serve a synthetic cell platform for research on connective tissue disease and evaluation of 
novel therapeutic agents. 
 
Ackowledgments : The authors acknowledge financial supports from ANR E-DETACHPEM 
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Experimental section  
 
Synthesis of polymers. Thin layer chromatography (TLC) was performed on precoated plates (0.25 mm 
Silica Gel 60, F254, Merck, Darmstadt, Germany). Products were purified by chromatography over silica 
gel (Silica Gel 60, 40-63 µm, Merck, Darmstadt, Germany). NMR spectra were recorded on Bruker 300 
MHz Avance DPX and 400 MHz Avance 3 ultrashield+ instruments. 1H-, 13C-NMR chemical shifts  
are reported in ppm relative to their standard reference (1H: CHCl3 at 7.27 ppm, DMF (-CH3) at 
2.88 ppm, tert-butanol at 1.24 ppm; 13C: CDCl3 at 77.0 ppm). Mass Spectra (MS) were recorded on an 
Agilent MSD SQ 1200SL instrument, using multimode APCI / Electrospray (ESI) mode and coupled to 
HPLC 1200SL. Mass data are reported in mass units (m/z). Unless otherwise specified, all chemicals 
were reagent grade and were used as received: sulfur flowers and 4-vinylbenzoic acid were purchased 
from Alfa Aesar (Bischeim, France) sodium sulfide, N-hydroxysuccinimide, N-Boc-2,2’-
(ethylenedioxy)diethylamine were all purchased from Aldrich (St. Quentin Fallavier, France), N,N’-
dicyclohexyl-carbodiimide was purchased from Acros (Thermo Fisher Scientific, Strasbourg, France). 
 
Synthesis of BVBA. A solution of bromine (360 µL, 6.95 mmol) in chloroform (5 mL) was added 
dropwise at 0°C to a solution of vinylbenzoic acid (VBA) (1g, 6.74 mmol) in chloroform (20 mL). The 
solution was strirred at room temperature for 4 hours. Chloroform was removed under vacuum to give 
2.05 g (98%) of BVBA as a white solid. 1H NMR (300 MHz, CDCl3)  4.05 (m, 2H, CH2), 5.16 (dd, J = 
5.2, 11.0 Hz, 1H, CHBr), 7.52 (d, J = 8.4 Hz, 2H, CHAr), 8.13 (d, J = 8.4 Hz, 2H, CHAr), 
13C NMR (100 
MHz, CDCl3)  34.43 (CH2), 49.30 (CHBr), 128.14 (CHAr), 130.06 (CArCHBr), 130.98 (CHAr), 144.56 
(CArCOOH). 
 
Synthesis of Polymer PVBACOO-. A solution of sulfur flowers (114 mg, 3.57 mmol) and sodium sulfide 
(278 mg, 3.57 mmol) in water (10 mL) was stirred 2 hours at 70°C. Then a solution of BVBA (1.1 g, 
3.57 mmol) and sodium hydroxide (143 mg, 3.57 mmol) in water (10 mL) was added. The mixture was 
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stirred at room temperature for 24 hours. The polymer was precipited in ethanol to give 500 mg as a 
white solid. 1H NMR (300 MHz, D2O, reference tert-butanol)  2.5-4.5 (m, 3nH, CHCH2), 7.27 (m, 
2nH, CHAr), 7.87 (m, 2nH, CHAr). n is the degree of polymerisation (DPn). PVBACOO
- has a mean 
molecular weight of Mw = 28 × 103 g/mol and a polydispersity Mw/Mn = 1.69, determined by Steric 
Exclusion Chromatograpy - Multi Angle Light Scattering (SEC-MALS). 
 
Synthesis of BVBANHBoc. To a solution of BVBA (872 mg, 2.83 mmol) in dichloromethane (40 mL), 
N,N’-dicyclohexylcarbodiimide (636 mg, 3.084 mmol) and N-hydroxysuccinimide (354 mg, 3.084 
mmol) were added and stirred at room temperature for 30 minutes. A solution of N-Boc-2,2’-
(ethylenedioxy)diethylamine (656 mg, 2.83 mmol) in dichloromethane (10 mL) was added dropwise 
and kept under stirring at room temperature for 15 hours. After removing the precipitate, the residue was 
purified by silica-gel chromatography to afford 544 mg (40%) of BVBANHBoc as a colorless oil. 1H 
NMR (300 MHz, CDCl3)  1.44 (s, 9H, C(CH3)3), 3.29 (m, 2H, CH2NHBoc), 3.53-3.72 (m, 10H, CH2 
PEG), 3.97-4.09 (m, 2H, CH2Br), 4.98 (NH), 5.14 (dd, J = 5.2, 10.7 Hz, 1H, CHBr), 6.77 (NH), 7.47 
(m, 2H, CHAr), 7.81 (m, 2H, CHAr), 
13C NMR (100 MHz, CDCl3)  28.9 ((CH3)3), 34.9 (CH2Br), 39.8-
40.3 (NHCH2 and CH2NH), 49.8 (CHBr), 70.6 (CH2 PEG), 127.8-128.1(CHAr), 135.1 (CArCHBr), 141.9 
(CArCOOH), 156.1 and 167.0 (CO), LR-MS (ESI) calcd for C20H30Br2N2NaO5 (M+Na)
+ : 561.0399; 
found 561.0419. 
N
H
O
Br
Br
O
O
H
N O
O
OHO OHO
Br2, CHCl3
Br
Br
2) Na2S2, H2O
1) NaOH, H2O
O-Na+O
S
S
DCC, NHS, CH2Cl2
n
N
H
O
S
O
O
NH3
+TFA-
S
n
2) TFA, CH2Cl2
VBA BVBA
PVBACOO-
PVBANH3
+
1) Na2S2, H2O
H2N
O
O
H
N O
O
BVBANHBoc
 
Scheme 2: Schematic representation of synthesis of polymer PVBACOO- and PVBANH3
+ 
 
Synthesis of polymer PVBANHBoc. A solution of sulfur flowers (32 mg, 1.00 mmol) and sodium sulfide 
(78 mg, 1.00 mmol) in water (6 mL) was stirred 2 hours at 70°C. The reaction mixture was added 
dropwise to a solution of BVBANHBoc (540 mg, 1.034 mmol) in DMF (10 mL). The solution was 
strirred at room temperature for 24 hours. The solution was diluted in ethanol (20 mL) and the polymer 
was precipited into chilled diethyl ether (500mL) to give 264 mg (64%) of the polymer PVBANHBoc as 
white a solid. 1H NMR (300 MHz, D2O, reference DMF)  1.30-1.38 (m, 9nH, C(CH3)3), 3-3.81 (m, 
15nH, CH2 PEG, CHCH2S), 7.19-7.92 (m, 4nH, CHAr). n is the degree of polymerisation (DPn). 
 
Synthesis of polymer PVBANH3
+. To a solution of polymer PVBANHBoc (260 mg, 0.64 mmol) in 
dichloromethane (20 mL), trifluoroacetic acid (10 mL) was added and stirred at room temperature for 24 
hours. The solvent was removed by vacuum, water (20 mL) was added to dissolve the polymer. After 
filtration and lyophilization, the polymer PVBANH3
+ was allowed as a slightly green solid, 290 mg 
(100 %). 1H NMR (300 MHz, D2O, reference tert-butanol)  3.13 (s, 2nH, -CH2NH2), 3.57 (m, 10nH, 
CH2 PEG), 2.7-4.5 (bm, 3nH, CHCH2S), 7.25 (bm, 2nH, CHAr), 7.75 (bm, 2nH, CHAr). n is the degree 
of polymerisation (DPn). 
 
Chemicals and polyelectrolyte solutions. Poly(allylamine hydrochloride) (PAH, Mw= 7 × 104 g/mol), 
 17 
Poly(sodium 4-styrenesulfonate) (PSS, Mw = 7.0 × 104 g/mol), poly(ethylene imine) (PEI, Mw= 75 × 
104 g/mol), (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (Hepes) and Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) were all purchased from Sigma (St. Quentin Fallavier, 
France). 10 mM Hepes-150 mM NaCl buffer at pH 7.4 was prepared to dissolve polyelectrolytes and 
TCEP using ultrapure water (MilliQ- plus system, Millipore) with a resistivity of 18.2 MΩ.cm. All 
polyelectrolyte solutions were prepared at 0.5 mg/mL by dissolution of adequate amounts of 
polyelectrolyte powders in Hepes-NaCl buffer. The solutions were freshly prepared before use. 
 
Quartz crystal microbalance. The construction of multilayer films was monitored in situ by quartz 
crystal microbalance with dissipation monitoring QCM (Q-Sense E4, Götenborg, Sweden). The QCM 
technique consists in measuring the resonance frequency changes (Δf) induced by polyelectrolyte 
adsorption on a quartz crystal. The quartz crystal is excited at its fundamental frequency (5 MHz), and 
the measurements are performed at the first, third, fifth and seventh overtones (denoted by ν = 1, 3, 5 
and 7, respectively) corresponding to about 5, 15, 25, and 35 MHz, respectively. Changes in the 
resonance frequencies, Δf once the excitation is switched off are measured at these four frequencies. 
The quartz crystals used here are coated with a ~50 nm SiO2 film. The sensor is fixed in removable flow 
modules with inlet and outlet and maintained at 22°C. In each experiment, 600 μL of Hepes-NaCl 
solution were injected into the measurement cell. After stabilization of the signals (shift in reduced 
frequency typically lower than 0.5 Hz/min), 600 μL of the polycation solution dissolved in a Hepes-
NaCl buffer was injected. This solution was left in the cell for 5 min, and rinsed with the Hepes-NaCl 
buffer and left again for 5 min. During the whole process, the frequency shifts were continuously 
recorded as a function of time. The same procedure was used for the deposition of the polyanion. The 
construction was pursued by alternate depositions of polycation and polyanion. A positive shift in the 
opposite of the normalized frequency shift, -Δfν/ν, can be associated, in first approximation, with an 
increase of the mass adsorbed on the crystal. In our case; the normalized frequency shifts (15, 25 and 35 
MHz) are superimposed then the Sauerbrey's relation can be applied to determine the thickness 
adsorbed.43 
 
Buildup of multilayered films on glass coverslips. Polyelectrolyte multilayers films have been 
prepared in 24 wells plates on glass coverslips (VWR, Strasbourg, France) pretreated with 0.1 M 
SDS for 15 min followed by 0.1 M HCl for 15 min at 100°C and rinsed with extensively distilled 
water between each treatment. 300 µL of polycation solution were deposited for 10 min on glass 
coverslips followed by three rinses with Hepes-NaCl buffer. Then, 300 µL of polyanionic solution 
were added for 10 min followed by three rinses. These steps were repeated according to the chosen 
film scheme, typically (PAH/PSS)n-PAH and (PVBANH3
+/PVBACOO-)m-(PAH/PSS)n-PAH films. 
 
Cell culture on multilayer films. Gingival fibroblasts (HGFs) were isolated from human gingival 
connective tissue of healthy individuals according to a protocol approved by the ethics committee for 
patient protection of CPP Strasbourg Hospitals. Gingival tissues were obtained from gingival samples 
without inflammation removed for tooth extraction purposes, cut into small pieces, placed into culture 
dishes, and incubated in a humidified atmosphere of 95% air and 5% CO2 at 37°C for 30 min. Then, 
culture medium (DMEM with 20% FBS, 100 μg/mL penicillin-streptomycin and 2 μg/mL Fungizone®, 
Gibco) was added. After reaching confluency, the cells were harvested using 0.25% trypsin. HGFs were 
used between the 4th and 6th passage. For phenotype characterization, HGFs were seeded in 24 wells 
plates at the density of 3 × 104 cells per cm2 over glass coverslips covered with different architectures. 
 
Detachment of HGFs cell sheet. After 30 days of HGFs culture on (PVBANH3
+/PVBACOO-)10-
(PAH/PSS)10-PAH film, the cell layer was detached by contact with TCEP during less than 30 minutes. 
Tweezers were used to peel the cell sheet. After detachment, the cell sheet was immersed on cell culture 
medium. 
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Viability assay. The measurement of cell viability was done by the AlamarBlueTM assay (Biosource 
International). This assay is based on the reduction of the blue, non fluorescent dye resazurin to the pink 
and fluorescent dye resorufin by living cells. Viability was assessed for different times. After rinsing 
cells with PBS 10% reagent in complete medium was incubated for 3 hours. After incubation optical 
density (OD) at 570 nm and 630 nm were determined with a microplate reader. The percentage of 
reduction of AlamarBlueTM was calculated according to the procedure provided by the manufacturer. 
 
Immunocytochemical detection of collagen type I, F-actin, MMP2 and alpha-actin. Cells were fixed 
with 3.7% paraformaldehyde for 10 min at 4°C, permeabilized in 0.25% Triton X-100 in PBS for 10 
min, and blocked in 1% BSA-PBS for 30 min. Thereafter, cells were incubated for 3 hours at room 
temperature with rabbit anti-collagen type I (COL1) antibody (Ab-cam), mouse monoclonal anti-human 
smooth muscle α-actin (α-SMA) (Dako), or anti-metalloprotease 2 (MMP2) at the dilution of 1/200 and 
1/50 respectively. Slides were then extensively washed with PBS, and a secondary antibody (Invitrogen 
Alexa fluor anti-rabbit IgG or Rockland goat polyclonal FITC anti-mouse IgG, respectively) was added 
at a dilution of 1/1000 and incubated for 2 hours at room temperature in the dark, followed by nuclear 
counterstaining with DAPI (50 ng/ml) (Invitrogen) incubated for 2 min at room temperature. F-actin 
filaments were observed by incubation of cells for 30 min at room temperature with 5 × 10-5 mg/mL 
phalloidin-tetramethylrhodamine B isothiocyanate (Sigma-Aldrich). Washed slides were mounted on 
blades with DAKO fluorescent mounting medium (DAKO) and fluorescence distribution was examined 
by means of an inverse fluorescence microscope (Axiovert, Zeiss).  
 
Quantitative Real-time Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR). Total RNA was 
isolated from the cells on each well after trypsin extraction with the RNeasy Mini Kit from QIAGEN. 
The amount of RNA in each sample was quantified using a NanoDrop spectrophotometer (Thermo 
Scientific) and adjusted at 150ng/μL. cDNA strand was generated from 10 μL total RNA using the 
Superscript II kit from Invitrogen. The amplification of cDNAs was performed in separate reactions of 
40 cycles each in a Biorad PCR system (Bio-Rad MyiQTM2 Two-Color Real-Time PCR Detection 
System) using the Quantitec SYBR Green PCR Kit and gene-specific primer pairs (QuantiTec Primer) 
from QIAGEN for α-SMA, and the beta2 microglobulin (BM2), hypoxanthine phosphoribosyl 
transferase1 (HPRT1) and glyceraldehyde phosphate dehydrogenase (GAPDH) housekeeping gene 
controls. Gene expression level stability was analyzed by the GeNorm algorithm. The experiment was 
repeated three times and the analysis of marker expression was performed using the iQTM5 Optical 
System Software.  
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